1. Scrip
  2. >>Business

Sanofi’s Emerging Markets Steady Despite Venezuela Volatility

 
• By Jung Won Shin

Sanofi reported steady growth in emerging markets in the second quarter despite the volatility in Venezuela and helped by continued momentum in China.

pills

Sanofi performed "very consistently" in emerging markets in the second quarter, with steady growth across geographies, according to Olivier Charmeil, the French group’s executive vice president, General Medicines & Emerging Markets, although the economic turmoil in Venezuela is expected to drag on performance this year.

Group emerging market sales were "broadly stable" versus last year, rising by 7% excluding Venezuela, CEO Olivier Brandicourt said during...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Scrip

Big Top-Level Shifts At Sun: Ganorkar Is MD, Ex-Takeda Exec To Helm US Business

 
• By Anju Ghangurde

Sun’s founder hands top job to company longtimer Kirti Ganorkar as the firm implements a “structured and forward-looking” succession plan, while Richard Ascroft will lead the Indian drugmaker’s North America business.

UCB Follows Fellow European Pharmas With Major US Investment

 
• By Kevin Grogan

The Belgian drugmaker is boosting its biologics capacity over the pond.

AstraZeneca Taps Into China’s R&D Engine With CSPC Alliance

 
• By Andrew McConaghie

After in-licensing a cardiovascular candidate last year, AstraZeneca has signed a strategic drug discovery alliance, which could generate billions of dollars in payments to the Chinese firm.